Viatris recalls
FDA enforcement reports naming Viatris as the recalling firm.
- Recall reports
- 25
- Class I (serious)
- 1
- Most recent report
- Apr 15, 2026
- Apr 15, 2026Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Dist…Drug · Viatris, Inc.Failed Dissolution SpecificationsClass II
- Jan 22, 2025Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distri…Drug · Viatris IncFailed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.Class II
- Jan 22, 2025Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distrib…Drug · Viatris IncFailed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.Class II
- Dec 18, 2024Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-18…Drug · Viatris IncSuperpotent Drug and Subpotent Drug: potency failures obtainedClass II
- Dec 18, 2024Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-180…Drug · Viatris IncSuperpotent Drug and Subpotent Drug: potency failures obtainedClass II
- Dec 18, 2024Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC 0378-18…Drug · Viatris IncSuperpotent Drug and Subpotent Drug: potency failures obtainedClass II
- Dec 18, 2024Levothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-18…Drug · Viatris IncSuperpotent Drug and Subpotent Drug: potency failures obtainedClass II
- Dec 18, 2024Levothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-18…Drug · Viatris IncSuperpotent Drug and Subpotent Drug: potency failures obtainedClass II
- Dec 18, 2024Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-18…Drug · Viatris IncSuperpotent Drug and Subpotent Drug: potency failures obtainedClass II
- Dec 18, 2024Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-18…Drug · Viatris IncSuperpotent Drug and Subpotent Drug: potency failures obtainedClass II
- Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0378-180…
- Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0378-180…
- Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-180…
- Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC 0378-18…
- Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in…
- Cardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in…
- Valacyclovir Tablets USP, 500 mg, 90 count bottles, Rx Only, Manufactured for: Mylan Ph…
- Levsin injection (hyoscyamine sulfate injection, USP), 0
- Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc
- Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, Fo…
- Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vial…
- Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only, Distrib…
- alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by:…
- Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Dis…
- Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pha…
Page 1 of 3